Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus RecommendationsFunda Meric‐Bernstam, Jeffrey A. Moscow, Michael W. Lloyd et al.|Molecular Cancer Therapeutics|2024Cited by 21